1 Market Overview

1.1 Product Overview and Scope of Phage Therapy

1.2 Classification of Phage Therapy by Type

1.2.1 Overview: Global Phage Therapy Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Phage Therapy Revenue Market Share by Type in 2020

1.2.3 Oral

1.2.4 External Application

1.2.5 Surgical Treatment

1.3 Global Phage Therapy Market by Application

1.3.1 Overview: Global Phage Therapy Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Human Medicine

1.3.3 Veterinary Science

1.3.4 Agriculture

1.4 Global Phage Therapy Market Size & Forecast

1.5 Global Phage Therapy Market Size and Forecast by Region

1.5.1 Global Phage Therapy Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Phage Therapy Market Size by Region, (2016-2021)

1.5.3 North America Phage Therapy Market Size and Prospect (2016-2026)

1.5.4 Europe Phage Therapy Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Phage Therapy Market Size and Prospect (2016-2026)

1.5.6 South America Phage Therapy Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Phage Therapy Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Phage Therapy Market Drivers

1.6.2 Phage Therapy Market Restraints

1.6.3 Phage Therapy Trends Analysis

2 Company Profiles

2.1 Phage International

2.1.1 Phage International Details

2.1.2 Phage International Major Business

2.1.3 Phage International Phage Therapy Product and Solutions

2.1.4 Phage International Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Phage International Recent Developments and Future Plans

2.2 Adaptive Phage Therapeutics

2.2.1 Adaptive Phage Therapeutics Details

2.2.2 Adaptive Phage Therapeutics Major Business

2.2.3 Adaptive Phage Therapeutics Phage Therapy Product and Solutions

2.2.4 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Adaptive Phage Therapeutics Recent Developments and Future Plans

2.3 AmpliPhi Biosciences

2.3.1 AmpliPhi Biosciences Details

2.3.2 AmpliPhi Biosciences Major Business

2.3.3 AmpliPhi Biosciences Phage Therapy Product and Solutions

2.3.4 AmpliPhi Biosciences Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 AmpliPhi Biosciences Recent Developments and Future Plans

2.4 C3J Therapeutics

2.4.1 C3J Therapeutics Details

2.4.2 C3J Therapeutics Major Business

2.4.3 C3J Therapeutics Phage Therapy Product and Solutions

2.4.4 C3J Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 C3J Therapeutics Recent Developments and Future Plans

2.5 Enbiotix

2.5.1 Enbiotix Details

2.5.2 Enbiotix Major Business

2.5.3 Enbiotix Phage Therapy Product and Solutions

2.5.4 Enbiotix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Enbiotix Recent Developments and Future Plans

2.6 InnoPhage

2.6.1 InnoPhage Details

2.6.2 InnoPhage Major Business

2.6.3 InnoPhage Phage Therapy Product and Solutions

2.6.4 InnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 InnoPhage Recent Developments and Future Plans

2.7 iNtODEWorld

2.7.1 iNtODEWorld Details

2.7.2 iNtODEWorld Major Business

2.7.3 iNtODEWorld Phage Therapy Product and Solutions

2.7.4 iNtODEWorld Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 iNtODEWorld Recent Developments and Future Plans

2.8 Intralytix

2.8.1 Intralytix Details

2.8.2 Intralytix Major Business

2.8.3 Intralytix Phage Therapy Product and Solutions

2.8.4 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Intralytix Recent Developments and Future Plans

2.9 Locus Biosciences

2.9.1 Locus Biosciences Details

2.9.2 Locus Biosciences Major Business

2.9.3 Locus Biosciences Phage Therapy Product and Solutions

2.9.4 Locus Biosciences Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Locus Biosciences Recent Developments and Future Plans

2.10 Phagomed

2.10.1 Phagomed Details

2.10.2 Phagomed Major Business

2.10.3 Phagomed Phage Therapy Product and Solutions

2.10.4 Phagomed Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Phagomed Recent Developments and Future Plans

2.11 Pherecydes Pharma

2.11.1 Pherecydes Pharma Details

2.11.2 Pherecydes Pharma Major Business

2.11.3 Pherecydes Pharma Phage Therapy Product and Solutions

2.11.4 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Pherecydes Pharma Recent Developments and Future Plans

2.12 TechnoPhage

2.12.1 TechnoPhage Details

2.12.2 TechnoPhage Major Business

2.12.3 TechnoPhage Phage Therapy Product and Solutions

2.12.4 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 TechnoPhage Recent Developments and Future Plans

2.13 Eligo Bioscience

2.13.1 Eligo Bioscience Details

2.13.2 Eligo Bioscience Major Business

2.13.3 Eligo Bioscience Phage Therapy Product and Solutions

2.13.4 Eligo Bioscience Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Eligo Bioscience Recent Developments and Future Plans

2.14 Phagelux

2.14.1 Phagelux Details

2.14.2 Phagelux Major Business

2.14.3 Phagelux Phage Therapy Product and Solutions

2.14.4 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Phagelux Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Phage Therapy Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Phage Therapy Players Market Share

3.2.2 Top 10 Phage Therapy Players Market Share

3.2.3 Market Competition Trend

3.3 Phage Therapy Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Phage Therapy Revenue and Market Share by Type (2016-2021)

4.2 Global Phage Therapy Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Phage Therapy Revenue Market Share by Application (2016-2021)

5.2 Phage Therapy Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Phage Therapy Revenue by Type (2016-2026)

6.2 North America Phage Therapy Revenue by Application (2016-2026)

6.3 North America Phage Therapy Market Size by Country

6.3.1 North America Phage Therapy Revenue by Country (2016-2026)

6.3.2 United States Phage Therapy Market Size and Forecast (2016-2026)

6.3.3 Canada Phage Therapy Market Size and Forecast (2016-2026)

6.3.4 Mexico Phage Therapy Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Phage Therapy Revenue by Type (2016-2026)

7.2 Europe Phage Therapy Revenue by Application (2016-2026)

7.3 Europe Phage Therapy Market Size by Country

7.3.1 Europe Phage Therapy Revenue by Country (2016-2026)

7.3.2 Germany Phage Therapy Market Size and Forecast (2016-2026)

7.3.3 France Phage Therapy Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Phage Therapy Market Size and Forecast (2016-2026)

7.3.5 Russia Phage Therapy Market Size and Forecast (2016-2026)

7.3.6 Italy Phage Therapy Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Phage Therapy Revenue by Type (2016-2026)

8.2 Asia-Pacific Phage Therapy Revenue by Application (2016-2026)

8.3 Asia-Pacific Phage Therapy Market Size by Region

8.3.1 Asia-Pacific Phage Therapy Revenue by Region (2016-2026)

8.3.2 China Phage Therapy Market Size and Forecast (2016-2026)

8.3.3 Japan Phage Therapy Market Size and Forecast (2016-2026)

8.3.4 South Korea Phage Therapy Market Size and Forecast (2016-2026)

8.3.5 India Phage Therapy Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Phage Therapy Market Size and Forecast (2016-2026)

8.3.7 Australia Phage Therapy Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Phage Therapy Revenue by Type (2016-2026)

9.2 South America Phage Therapy Revenue by Application (2016-2026)

9.3 South America Phage Therapy Market Size by Country

9.3.1 South America Phage Therapy Revenue by Country (2016-2026)

9.3.2 Brazil Phage Therapy Market Size and Forecast (2016-2026)

9.3.3 Argentina Phage Therapy Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Phage Therapy Revenue by Type (2016-2026)

10.2 Middle East & Africa Phage Therapy Revenue by Application (2016-2026)

10.3 Middle East & Africa Phage Therapy Market Size by Country

10.3.1 Middle East & Africa Phage Therapy Revenue by Country (2016-2026)

10.3.2 Turkey Phage Therapy Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Phage Therapy Market Size and Forecast (2016-2026)

10.3.4 UAE Phage Therapy Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Phage Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Phage Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Phage Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Phage Therapy Revenue (USD Million) by Region (2016-2021)

Table 5. Global Phage Therapy Revenue Market Share by Region (2021-2026)

Table 6. Phage International Corporate Information, Head Office, and Major Competitors

Table 7. Phage International Major Business

Table 8. Phage International Phage Therapy Product and Solutions

Table 9. Phage International Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Adaptive Phage Therapeutics Corporate Information, Head Office, and Major Competitors

Table 11. Adaptive Phage Therapeutics Major Business

Table 12. Adaptive Phage Therapeutics Phage Therapy Product and Solutions

Table 13. Adaptive Phage Therapeutics Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. AmpliPhi Biosciences Corporate Information, Head Office, and Major Competitors

Table 15. AmpliPhi Biosciences Major Business

Table 16. AmpliPhi Biosciences Phage Therapy Product and Solutions

Table 17. AmpliPhi Biosciences Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. C3J Therapeutics Corporate Information, Head Office, and Major Competitors

Table 19. C3J Therapeutics Major Business

Table 20. C3J Therapeutics Phage Therapy Product and Solutions

Table 21. C3J Therapeutics Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Enbiotix Corporate Information, Head Office, and Major Competitors

Table 23. Enbiotix Major Business

Table 24. Enbiotix Phage Therapy Product and Solutions

Table 25. Enbiotix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. InnoPhage Corporate Information, Head Office, and Major Competitors

Table 27. InnoPhage Major Business

Table 28. InnoPhage Phage Therapy Product and Solutions

Table 29. InnoPhage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. iNtODEWorld Corporate Information, Head Office, and Major Competitors

Table 31. iNtODEWorld Major Business

Table 32. iNtODEWorld Phage Therapy Product and Solutions

Table 33. iNtODEWorld Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Intralytix Corporate Information, Head Office, and Major Competitors

Table 35. Intralytix Major Business

Table 36. Intralytix Phage Therapy Product and Solutions

Table 37. Intralytix Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Locus Biosciences Corporate Information, Head Office, and Major Competitors

Table 39. Locus Biosciences Major Business

Table 40. Locus Biosciences Phage Therapy Product and Solutions

Table 41. Locus Biosciences Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Phagomed Corporate Information, Head Office, and Major Competitors

Table 43. Phagomed Major Business

Table 44. Phagomed Phage Therapy Product and Solutions

Table 45. Phagomed Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Pherecydes Pharma Corporate Information, Head Office, and Major Competitors

Table 47. Pherecydes Pharma Major Business

Table 48. Pherecydes Pharma Phage Therapy Product and Solutions

Table 49. Pherecydes Pharma Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. TechnoPhage Corporate Information, Head Office, and Major Competitors

Table 51. TechnoPhage Major Business

Table 52. TechnoPhage Phage Therapy Product and Solutions

Table 53. TechnoPhage Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Eligo Bioscience Corporate Information, Head Office, and Major Competitors

Table 55. Eligo Bioscience Major Business

Table 56. Eligo Bioscience Phage Therapy Product and Solutions

Table 57. Eligo Bioscience Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Phagelux Corporate Information, Head Office, and Major Competitors

Table 59. Phagelux Major Business

Table 60. Phagelux Phage Therapy Product and Solutions

Table 61. Phagelux Phage Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Global Phage Therapy Revenue (USD Million) by Players (2019-2021)

Table 63. Global Phage Therapy Revenue Share by Players (2019-2021)

Table 64. Breakdown of Phage Therapy by Company Type (Tier 1, Tier 2 and Tier 3)

Table 65. Phage Therapy Players Head Office, Products and Services Provided

Table 66. Phage Therapy Mergers & Acquisitions in the Past Five Years

Table 67. Phage Therapy New Entrants and Expansion Plans

Table 68. Global Phage Therapy Revenue (USD Million) by Type (2016-2021)

Table 69. Global Phage Therapy Revenue Share by Type (2016-2021)

Table 70. Global Phage Therapy Revenue Forecast by Type (2021-2026)

Table 71. Global Phage Therapy Revenue by Application (2016-2021)

Table 72. Global Phage Therapy Revenue Forecast by Application (2021-2026)

Table 73. North America Phage Therapy Revenue by Type (2016-2021) & (USD Million)

Table 74. North America Phage Therapy Revenue by Type (2021-2026) & (USD Million)

Table 75. North America Phage Therapy Revenue by Application (2016-2021) & (USD Million)

Table 76. North America Phage Therapy Revenue by Application (2021-2026) & (USD Million)

Table 77. North America Phage Therapy Revenue by Country (2016-2021) & (USD Million)

Table 78. North America Phage Therapy Revenue by Country (2021-2026) & (USD Million)

Table 79. Europe Phage Therapy Revenue by Type (2016-2021) & (USD Million)

Table 80. Europe Phage Therapy Revenue by Type (2021-2026) & (USD Million)

Table 81. Europe Phage Therapy Revenue by Application (2016-2021) & (USD Million)

Table 82. Europe Phage Therapy Revenue by Application (2021-2026) & (USD Million)

Table 83. Europe Phage Therapy Revenue by Country (2016-2021) & (USD Million)

Table 84. Europe Phage Therapy Revenue by Country (2021-2026) & (USD Million)

Table 85. Asia-Pacific Phage Therapy Revenue by Type (2016-2021) & (USD Million)

Table 86. Asia-Pacific Phage Therapy Revenue by Type (2021-2026) & (USD Million)

Table 87. Asia-Pacific Phage Therapy Revenue by Application (2016-2021) & (USD Million)

Table 88. Asia-Pacific Phage Therapy Revenue by Application (2021-2026) & (USD Million)

Table 89. Asia-Pacific Phage Therapy Revenue by Region (2016-2021) & (USD Million)

Table 90. Asia-Pacific Phage Therapy Revenue by Region (2021-2026) & (USD Million)

Table 91. South America Phage Therapy Revenue by Type (2016-2021) & (USD Million)

Table 92. South America Phage Therapy Revenue by Type (2021-2026) & (USD Million)

Table 93. South America Phage Therapy Revenue by Application (2016-2021) & (USD Million)

Table 94. South America Phage Therapy Revenue by Application (2021-2026) & (USD Million)

Table 95. South America Phage Therapy Revenue by Country (2016-2021) & (USD Million)

Table 96. South America Phage Therapy Revenue by Country (2021-2026) & (USD Million)

Table 97. Middle East & Africa Phage Therapy Revenue by Type (2016-2021) & (USD Million)

Table 98. Middle East & Africa Phage Therapy Revenue by Type (2021-2026) & (USD Million)

Table 99. Middle East & Africa Phage Therapy Revenue by Application (2016-2021) & (USD Million)

Table 100. Middle East & Africa Phage Therapy Revenue by Application (2021-2026) & (USD Million)

Table 101. Middle East & Africa Phage Therapy Revenue by Country (2016-2021) & (USD Million)

Table 102. Middle East & Africa Phage Therapy Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Phage Therapy Picture

Figure 2. Global Phage Therapy Revenue Market Share by Type in 2020

Figure 3. Oral

Figure 4. External Application

Figure 5. Surgical Treatment

Figure 6. Phage Therapy Revenue Market Share by Application in 2020

Figure 7. Human Medicine Picture

Figure 8. Veterinary Science Picture

Figure 9. Agriculture Picture

Figure 10. Global Phage Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 11. Global Phage Therapy Revenue and Forecast (2016-2026) & (USD Million)

Figure 12. Global Phage Therapy Revenue Market Share by Region (2016-2026)

Figure 13. Global Phage Therapy Revenue Market Share by Region in 2020

Figure 14. North America Phage Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 15. Europe Phage Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Asia-Pacific Phage Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. South America Phage Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Middle East and Africa Phage Therapy Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Phage Therapy Market Drivers

Figure 20. Phage Therapy Market Restraints

Figure 21. Phage Therapy Market Trends

Figure 22. Phage International Recent Developments and Future Plans

Figure 23. Adaptive Phage Therapeutics Recent Developments and Future Plans

Figure 24. AmpliPhi Biosciences Recent Developments and Future Plans

Figure 25. C3J Therapeutics Recent Developments and Future Plans

Figure 26. Enbiotix Recent Developments and Future Plans

Figure 27. InnoPhage Recent Developments and Future Plans

Figure 28. iNtODEWorld Recent Developments and Future Plans

Figure 29. Intralytix Recent Developments and Future Plans

Figure 30. Locus Biosciences Recent Developments and Future Plans

Figure 31. Phagomed Recent Developments and Future Plans

Figure 32. Pherecydes Pharma Recent Developments and Future Plans

Figure 33. TechnoPhage Recent Developments and Future Plans

Figure 34. Eligo Bioscience Recent Developments and Future Plans

Figure 35. Phagelux Recent Developments and Future Plans

Figure 36. Global Phage Therapy Revenue Share by Players in 2020

Figure 37. Phage Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Phage Therapy Revenue Market Share in 2020

Figure 39. Global Top 10 Players Phage Therapy Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Phage Therapy Revenue Share by Type in 2020

Figure 42. Global Phage Therapy Market Share Forecast by Type (2021-2026)

Figure 43. Global Phage Therapy Revenue Share by Application in 2020

Figure 44. Global Phage Therapy Market Share Forecast by Application (2021-2026)

Figure 45. North America Phage Therapy Sales Market Share by Type (2016-2026)

Figure 46. North America Phage Therapy Sales Market Share by Application (2016-2026)

Figure 47. North America Phage Therapy Revenue Market Share by Country (2016-2026)

Figure 48. United States Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Phage Therapy Sales Market Share by Type (2016-2026)

Figure 52. Europe Phage Therapy Sales Market Share by Application (2016-2026)

Figure 53. Europe Phage Therapy Revenue Market Share by Country (2016-2026)

Figure 54. Germany Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Phage Therapy Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Phage Therapy Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Phage Therapy Revenue Market Share by Region (2016-2026)

Figure 62. China Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Phage Therapy Sales Market Share by Type (2016-2026)

Figure 69. South America Phage Therapy Sales Market Share by Application (2016-2026)

Figure 70. South America Phage Therapy Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Phage Therapy Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Phage Therapy Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Phage Therapy Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Phage Therapy Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source